Latest Insider Transactions at Bellicum Pharmaceuticals, Inc (BLCM)
This section provides a real-time view of insider transactions for Bellicum Pharmaceuticals, Inc (BLCM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BELLICUM PHARMACEUTICALS, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BELLICUM PHARMACEUTICALS, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 22
2023
|
Baker Bros. Advisors LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,116,349
+47.14%
|
-
|
|
Jan 03
2023
|
Jon P Stonehouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
121,452
+37.31%
|
-
|
|
Jan 03
2023
|
Reid M Huber Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,196
+36.28%
|
-
|
|
Jan 03
2023
|
Stephen Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
74,739
+35.32%
|
-
|
|
Jan 03
2023
|
James M Daly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,414
+35.48%
|
-
|
|
Jan 03
2023
|
Judith V Klimovsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,414
+35.43%
|
-
|
|
Sep 01
2022
|
Judith V Klimovsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,082
+41.39%
|
-
|
|
Sep 01
2022
|
Stephen Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
43,400
+41.13%
|
-
|
|
Sep 01
2022
|
James M Daly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,082
+41.5%
|
-
|
|
Sep 01
2022
|
Reid M Huber Director |
BUY
Exercise of conversion of derivative security
|
Direct |
46,489
+41.33%
|
-
|
|
Sep 01
2022
|
Jon P Stonehouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,580
+36.88%
|
-
|
|
Jan 04
2022
|
Stephen Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,715
+50.0%
|
-
|
|
Jan 04
2022
|
Judith V Klimovsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,602
+26.87%
|
-
|
|
Jan 04
2022
|
James M Daly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,377
+27.66%
|
-
|
|
Jan 04
2022
|
Jon P Stonehouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
21,504
+48.86%
|
-
|
|
Jan 04
2022
|
James F Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,384
+50.0%
|
-
|
|
Jan 04
2022
|
Reid M Huber Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,494
+50.0%
|
-
|
|
Jan 19
2018
|
Baker Bros. Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
295,361
-6.64%
|
$2,067,527
$7.91 P/Share
|
|
Jan 18
2018
|
Baker Bros. Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
324,774
-6.81%
|
$2,598,192
$8.12 P/Share
|
|
Jan 17
2018
|
Baker Bros. Advisors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
260,600
-5.18%
|
$2,084,800
$8.63 P/Share
|